Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3000 of 3546 entries
View as:

Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

Phase: N/A Priority: Normal
NCT ID: NCT00600990 Org: User:
Start: 12/31/04 End: 07/31/06 Due: 07/31/07

Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02964507 Org: User:
Start: 09/26/19 End: 07/19/21 Due: 07/19/22

The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium

Phase: N/A Priority: Normal
NCT ID: NCT01899742 Org: User:
Start: 09/15/14 End: 07/22/15 Due: 07/22/16

Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03242434 Org: User:
Start: 01/29/18 End: 03/26/18 Due: 03/26/19

G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)

Phase: N/A Priority: Normal
NCT ID: NCT01205178 Org: User:
Start: 07/02/09 End: 04/01/13 Due: 04/01/14

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00363077 Org: User:
Start: 10/02/06 End: 11/17/06 Due: 11/17/07

Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02293148 Org: User:
Start: 11/17/14 End: 03/10/15 Due: 03/10/16

A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT03234036 Org: User:
Start: 08/02/17 End: 11/10/17 Due: 11/10/18

GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT01128738 Org: User:
Start: 04/30/10 End: 08/31/11 Due: 08/31/12

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02270944 Org: User:
Start: 11/20/14 End: 09/22/15 Due: 09/22/16

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01144299 Org: User:
Start: 06/17/10 End: 07/10/10 Due: 07/10/11

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00158899 Org: User:
Start: 08/31/04 End: 06/30/06 Due: 06/30/07

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT00753272 Org: User:
Start: 09/15/08 End: 01/05/11 Due: 01/05/12

Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

Phase: N/A Priority: Normal
NCT ID: NCT01046097 Org: User:
Start: 05/31/10 End: 07/31/13 Due: 07/31/14

To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

Phase: N/A Priority: Normal
NCT ID: NCT00363545 Org: User:
Start: 09/01/06 End: 04/12/07 Due: 04/12/08

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Phase: N/A Priority: Normal
NCT ID: NCT00533507 Org: User:
Start: 09/18/07 End: 06/06/08 Due: 06/06/09

A Study Of BRL49653C For The Treatment Of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00523913 Org: User:
Start: 11/30/05 End: 04/30/07 Due: 04/30/08

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

Phase: N/A Priority: Normal
NCT ID: NCT04869982 Org: User:
Start: 05/14/21 End: 04/20/23 Due: 04/20/24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus

Phase: N/A Priority: Normal
NCT ID: NCT01899703 Org: User:
Start: 03/10/14 End: 10/07/15 Due: 10/07/16

Epidemiology Study of Malaria Transmission Intensity in Africa

Phase: N/A Priority: Normal
NCT ID: NCT01190202 Org: User:
Start: 03/14/11 End: 12/20/13 Due: 12/20/14

Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01494649 Org: User:
Start: 09/30/11 End: 09/30/11 Due: 09/30/12

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Phase: N/A Priority: Normal
NCT ID: NCT01198769 Org: User:
Start: 11/11/10 End: 04/18/11 Due: 04/18/12

Intra Oral Kinetics of Fluoride Containing Dentifrices

Phase: N/A Priority: Normal
NCT ID: NCT02548156 Org: User:
Start: 09/30/15 End: 10/31/15 Due: 10/31/16

A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00393146 Org: User:
Start: 10/31/06 End: 01/31/08 Due: 01/31/09

Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg

Phase: N/A Priority: Normal
NCT ID: NCT01762800 Org: User:
Start: 02/28/13 End: 09/30/15 Due: 09/30/16